PHILADELPHIA, Oct. 3, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company”) announced that its Board of Directors has decided not to seek Stockholder approval regarding the proposed HEMISPHERx 2013 Equity Incentive Plan (the “Plan”) and has withdrawn this proposal from the agenda for its Annual Meeting scheduled for October 18, 2013.
Help employers find you! Check out all the jobs and post your resume.
